3 ms·
Yes, we are looking at IV, as others have done already clinically. We aren't looking at aptamers or other clever ways of binding small toxic biomolecules. I hop
by BiochemOki 7y ago
Yes, we are looking at IV, as others have done already clinically. We aren't looking at aptamers or other clever ways of binding small toxic biomolecules. I hope that other groups are!
- DrAwdeOccarim 7y agoThis is a pretty interesting paper: https://stm.sciencemag.org/content/8/333/333ra50 https://stm.sciencemag.org/content/8/333/333ra50 Is there a chance that you are developing CD that target 7KC but at the end of the day, it dissolved chol-containing plaques inherently and that's where you'll derive the benefit from?